ETON
NASDAQ · Pharmaceuticals
Eton Pharmaceuticals Inc
$23.76
+0.79 (+3.44%)
Open$22.81
Previous Close$22.97
Day High$23.89
Day Low$22.32
52W High$23.00
52W Low$11.09
Volume—
Avg Volume315.1K
Market Cap557.00M
P/E Ratio—
EPS$-0.25
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
-49.8% upside
Current
$23.76
$23.76
Target
$11.93
$11.93
$8.04
$11.93 avg
$13.91
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 38.18M | 31.46M | 122.17M |
| Net Income | -3,740,365 | -2,774,065 | 16.25M |
| Profit Margin | -9.8% | -9.3% | 13.3% |
| EBITDA | -1,419,108 | -1,110,962 | 25.36M |
| Free Cash Flow | — | — | 11.15M |
| Rev Growth | +21.4% | +21.4% | -8.5% |
| Debt/Equity | 1.22 | 1.22 | 0.20 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |